4Sc Ag Is A Biotechnology Company Based In Planegg Martinsriednear Munichgermanyfounded In 1997It Focuses On Developing Small Molecule Drugs For Cancer Treatmentparticularly In Areas With Significant Unmet Medical Needsthe Company Has Been Listed On The Prime Standard Of The Frankfurt Stock Exchange Since December 2005 The Company Specializes In Innovative Cancer Treatments That Leverage Epigenetic Mechanismsits Services Include Clinical Developmentwhere It Conducts Studies To Advance Drug Candidatesand Therapeutic Drug Development Aimed At Creating Novel Treatments For Key Cancer Indications4Sc Ag Also Seeks Partnerships With Pharmaceutical And Biotech Companies To Enhance Its Product Pipelineits Product Pipeline Features Several Promising Candidatesincluding Resminostat4Sc 202And 4Sc 208Which Are In Various Stages Of Clinical Developmentwith A Dedicated Team Of Approximately 47 Employees4Sc Ag Is Committed To Improving The Quality Of Life For Cancer Patients Through Effective And Well Tolerated Therapies
